Lessee, Operating Lease, Liability, to be Paid, Year Four in USD of Nurix Therapeutics, Inc. from Q4 2021 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Nurix Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and change rate from Q4 2021 to Q4 2024.
  • Nurix Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 30 Nov 2024 was $3.07M, a 2.71% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Change (%)

Nurix Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $3.07M +$81K +2.71% 30 Nov 2024 10-K 28 Jan 2025
Q4 2023 $2.99M +$323K +12.1% 30 Nov 2023 10-K 15 Feb 2024
Q4 2022 $2.67M +$932K +53.6% 30 Nov 2022 10-K 09 Feb 2023
Q3 2022 $2.67M 31 Aug 2022 10-Q 06 Oct 2022
Q2 2022 $2.67M 31 May 2022 10-Q 07 Jul 2022
Q4 2021 $1.74M 30 Nov 2021 10-K 28 Jan 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.